About 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid
1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid (PubChem CID 119137730) has the molecular formula C16H17BrN2O5
and a molecular weight of 397.23 g/mol. Its IUPAC name is 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid.
Analyze 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid?
The IUPAC name of 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid (CID 119137730) is 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid.
What is the SMILES notation for 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid?
The canonical SMILES for 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid is O=C(O)C1CCCCN1C(=O)CN1C(=O)COc2cc(Br)ccc21.
What is the InChIKey of 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid?
The InChIKey is UVFOFNNTACCUOD-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H17BrN2O5/c17-10-4-5-11-13(7-10)24-9-15(21)19(11)8-14(20)18-6-2-1-3-12(18)16(22)23/h4-5,7,12H,1-3,6,8-9H2,(H,22,23).
What are the key properties of 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid?
1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid has a molecular weight of 397.23 g/mol, XLogP of 1.64, 3 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]piperidine-2-carboxylic acid is sourced from PubChem (CID 119137730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).